ReCode Therapeutics: Clinical Trials

6 trials sponsored by ReCode Therapeutics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 active not recruiting. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3
Phase 21Active not recruiting 1

Follow ReCode Therapeutics: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Inhaled RCT1100 in Adults With PCD Caused by Pathogenic Mutations in the DNAI1 Gene to Measure Mucociliary Clearance
RCT1100 - Primary Ciliary Dyskinesia (PCD)
Phase 1CompletedReCode Therapeutics142024-10-222026-04-30
A Study to Assess the Safety, Tolerability, Ciliary Rescue, and Pharmacodynamics of RCT1100 in Adults With PCD
RCT1100 - Primary Ciliary Dyskinesia
Phase 1CompletedReCode Therapeutics72024-09-202025-10-08
A Phase 2 Study Evaluating Safety and Tolerability of RCT2100 (CFTR mRNA) in Healthy Participants and in Participants With CF
RCT2100, Placebo, Ivacaftor - Cystic Fibrosis
Phase 2Active not recruitingReCode Therapeutics1282024-02-012026-08-19
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
Sano Genetics Testing Kit - Primary Ciliary Dyskinesia
Active not recruitingReCode Therapeutics1502023-08-312025-05-11
A Longitudinal, Observational Study of Primary Ciliary Dyskinesia in Adults
Spirometry, Multiple Breath Washout (MBW), Mucociliary Clearance (MCC) - Primary Ciliary Dyskinesia
CompletedReCode Therapeutics312023-03-082026-05-04
Study Evaluating the Safety and Tolerability of RCT1100 in Healthy and PCD Subjects
RCT1100 - Primary Ciliary Dyskinesia
Phase 1CompletedReCode Therapeutics92023-02-182025-04-29

Conditions studied

Ciliary Motility Disorders (5)  ·  Kartagener Syndrome (4)  ·  Cystic Fibrosis (1)

Interventions

Mucociliary Clearance (1)  ·  Spirometry (1)  ·  ivacaftor (1)

Countries

United States (5)  ·  United Kingdom (3)  ·  New Zealand (2)  ·  Australia (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Netherlands (1)

Top investigators

John Matthews, MBBS, MCRP, PhD (4)  ·  Heymut Omran, MD (1)  ·  John G. Matthews, MBBS, MRCP, PhD (1)  ·  Kim G Nielsen, Dr Med Sci (1)  ·  Michael Loebinger, MD (1)  ·  Priya Ryali (1)  ·  Stephanie Davis (1)